Zorina S Galis

Author PubWeight™ 50.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003 8.61
2 From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003 3.94
3 Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 2003 3.15
4 Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007 2.91
5 Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res 2003 2.51
6 The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004 2.12
7 Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo. Radiology 2009 1.89
8 Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol 2002 1.80
9 On the value of portfolio diversity in heart, lung, and blood research. Am J Respir Crit Care Med 2012 1.57
10 Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng 2003 1.52
11 Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 2004 1.50
12 Sarcoidosis: a mysterious tale of inflammation, tissue remodeling, and matrix metalloproteinases. Hum Pathol 2002 1.44
13 Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 2004 1.31
14 Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension 2012 1.28
15 Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation 2002 1.19
16 Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 2004 1.18
17 Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc. J Biol Chem 2003 1.12
18 Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2003 1.12
19 Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity. Arterioscler Thromb Vasc Biol 2004 1.06
20 Putative murine models of plaque rupture. Arterioscler Thromb Vasc Biol 2007 1.01
21 Anatomy of success: the top 100 cited scientific reports focused on hypertension research. Hypertension 2013 0.98
22 The use of temperature-composition combinatorial libraries to study the effects of biodegradable polymer blend surfaces on vascular cells. Biomaterials 2004 0.97
23 Matrix metalloproteinase 9 facilitates collagen remodeling and angiogenesis for vascular constructs. Tissue Eng 2005 0.96
24 Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. Eur Heart J 2010 0.87
25 Matrix metalloproteinase-2 and -9 are associated with high stresses predicted using a nonlinear heterogeneous model of arteries. J Biomech Eng 2009 0.87
26 Vulnerable plaque: the devil is in the details. Circulation 2004 0.85
27 Designer blood vessels and therapeutic revascularization. Br J Pharmacol 2003 0.84
28 Optimization of isolation and functional characterization of primary murine aortic endothelial cells. Endothelium 2003 0.84
29 A fluorescence lifetime spectroscopy study of matrix metalloproteinases-2 and -9 in human atherosclerotic plaque. J Biophotonics 2011 0.80
30 Quantitative assessment of collagen assembly by live cells. J Biomed Mater Res A 2003 0.77
31 Neointimal cracks (plaque rupture?) and thrombosis in wrapped arteries without flow. Arterioscler Thromb Vasc Biol 2007 0.76
32 Matrix metalloproteinases and vascular endothelium-mononuclear cell close encounters. Trends Cardiovasc Med 2004 0.75
33 On the value of portfolio diversity in heart, lung, and blood research. Blood 2012 0.75